Exponential a rolling fund and the successful proof of concept that prompted the partners to launch Climate Capital Frontier, a traditional fund with the same thesis launching Q4 2022. For more information contact firstname.lastname@example.org
Exponential invests in companies that have the potential to save the world (literally). Focused on frontier technology companies, especially synthetic biology, that can provide radically effective solutions for climate change.
Part of the Climate Capital family of funds (see the team page for more details).
The climate crisis is a threat to humanity. In the same way the internet has entirely changed the global economy over the last 20 years, climate change and decarbonization will have the same, if not greater, impact on the next 20 years.
“We cannot solve our problems with the same thinking we used when we created them.” Albert Einstein.
We believe that slowing and reversing climate change will require new solutions across all industries, and we invest in companies bringing about this transformation. Biology-based companies, along with the platforms that support and enable their success, are a necessary next step in human technology. Today we need scalable solutions with exponential impact - solutions pushing the frontiers of biology, energy, and resource reutilization. We invest in pre-seed and seed companies taking this leap.
Exponential works in partnership with Climate Capital in addition to a network of founders and experts, to ensure extraordinary deal flow into the most promising syn-bio and frontier tech companies at the earliest stages. We co-invest with the best climate tech investors in the world including Lowercarbon Capital, Breakthrough Energy Ventures, Draper Associates, At One Ventures, Indie Bio, 50 Years VC, and others.
For more information contact email@example.com